{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:17:48Z","timestamp":1791101868588,"version":"4.1.0"},"reference-count":12,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":2735,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tropical Med Int Health"],"published-print":{"date-parts":[[2001,1]]},"abstract":"<jats:p> <jats:bold>R\u00e9sum\u00e9<\/jats:bold>Au cours d'un programme de lutte contre la bilharziose urinaire au Niger ayant pour objectif la r\u00e9duction de la morbidit\u00e9, nous avons conduit une enqu\u00eate afin d'\u00e9valuer la r\u00e9gression des l\u00e9sions apr\u00e8s traitement par praziquantel, de d\u00e9crire la vitesse de r\u00e9infestation et de d\u00e9terminer la p\u00e9riodicit\u00e9 de la chimioth\u00e9rapie de masse. 114 enfants scolaris\u00e9s \u00e2g\u00e9s de 7 \u00e0 15 ans, vivant en zone hyperend\u00e9mique, ont subi 10 examens p\u00e9riodiques au cours des 34 mois suivant un bilan initial et la prise de 40\u00a0mg\/kg de praziquantel. Tous les enfants ont \u00e9t\u00e9 trait\u00e9s ind\u00e9pendamment de leur statut parasitologique. Les examens pratiqu\u00e9s \u00e9taient: recherche d'oeufs de <jats:italic>S. haematobium<\/jats:italic> et d'h\u00e9maturie dans les urines, notation de l'aspect des urines, examen \u00e9chographique du tractus urinaire. Le nombre de perdus de vue a \u00e9t\u00e9 limit\u00e9. La pr\u00e9valence d'infestation initiale \u00e9tait de 75,4%. La r\u00e9infestation a \u00e9t\u00e9 apparente \u00e0 partir du 5\u00e8 mois et \u00e9tait de 47,1%\u00e0 la fin de l'enqu\u00eate. Les anomalies v\u00e9sicales ont tr\u00e8s rapidement mais incompl\u00e8tement r\u00e9gress\u00e9, probablement \u00e0 cause de la r\u00e9infestation (pr\u00e9valence initiale de 89,5%). Leur pr\u00e9valence a augment\u00e9\u00e0 partir du 8\u00e8 mois (72,4% au 34\u00e8 mois). Les dilatations du tractus urinaire sup\u00e9rieur ont r\u00e9gress\u00e9 plus lentement mais constamment jusqu'en fin de suivi (pr\u00e9valence initiale de 43%; 4,6% au 34\u00e8 mois). Trois ans apr\u00e8s le traitement, malgr\u00e9 la r\u00e9infestation, le niveau de morbidit\u00e9 g\u00e9n\u00e9ral (pr\u00e9valence et s\u00e9v\u00e9rit\u00e9 des l\u00e9sions) \u00e9taient largement inf\u00e9rieur \u00e0 celui observ\u00e9 initialement dans notre cohorte. Ceci plaide en faveur d'une p\u00e9riodicit\u00e9 longue de la chimioth\u00e9rapie de masse dans le contexte \u00e9pid\u00e9miologique de cette enqu\u00eate.<\/jats:p><jats:p><jats:bold>Summary<\/jats:bold> During a <jats:italic>Schistosoma haematobium<\/jats:italic> morbidity control program in Niger, we conducted a survey to describe the resolution of lesions after treatment with praziquantel, to determine reinfection rates and to define retreatment schedules. 114 schoolchildren (7\u201315 years old) living in an hyperendemic village underwent 10 successive examinations over 34\u00a0months following an initial evaluation and the administration of 40\u00a0mg\/kg of praziquantel. All children, whether apparently infected with <jats:italic>S. haematobium<\/jats:italic> or not, were treated. Egg output, microhaematuria, visual aspect of urine and abnormalities of the urinary tract by ultrasound were assessed. The initial prevalence of infection was 74.5%. Reinfection began 5\u00a0months after treatment and the final prevalence was 47.1%. Bladder abnormalities decreased rapidly, but incompletely, probably due to reinfestation (initial prevalence: 89.5%). Their prevalence increased 8\u00a0months after treatment to 72.4% at month 34. Dilatations of the upper urinary tract regressed more slowly but constantly until the end of the study (initial prevalence: 43%; 4.6% at month 34). Three years after treatment, despite reinfection, the general morbidity level (prevalence and severity of lesions) was lower than at baseline in our cohort, which would suggest the advantage of a long interval between mass treatments in the epidemiological context of our survey.<\/jats:p>","DOI":"10.1046\/j.1365-3156.2001.00660.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T21:35:37Z","timestamp":1047504937000},"page":"24-30","source":"Crossref","is-referenced-by-count":17,"title":["Suivi \u00e9chographique prolong\u00e9 d'enfants infest\u00e9s par <i>Schistosoma haematobium<\/i> apr\u00e8s traitement par praziquantel"],"prefix":"10.1111","volume":"6","author":[{"given":"G.","family":"Campagne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Garba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Barkir\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Vera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sidiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"35","article-title":"Contr\u00f4le de qualit\u00e9 lors de l'\u00e9valuation \u00e9chographique de la morbidit\u00e9 due \u00e0Schistosoma haematobium au Niger.","volume":"60","author":"Campagne G","year":"2000","journal-title":"M\u00e9decine Tropicale"},{"key":"e_1_2_5_3_1","first-page":"243","article-title":"Evaluation pr\u00e9liminaire des indicateurs indirects de morbidit\u00e9 au cours du programme de lutte contre la bilharziose urinaire dans la vall\u00e9e du fleuve Niger.","volume":"59","author":"Campagne G","year":"1999","journal-title":"M\u00e9decine Tropicale"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0035-9203(98)91057-4"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4269\/ajtmh.1996.55.170","article-title":"Schistosim: a microsimulation model for the epidemiology and control of schistosomiasis.","volume":"55","author":"Vlas DJ","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_5_6_1","first-page":"57","article-title":"Ultrasonic assessment of the regression of bladder and renal lesions due to Schistosoma haematobium after treatment with praziquantel.","volume":"69","author":"Devidas A","year":"1989","journal-title":"Annales de la Soci\u00e9t\u00e9 Belge de M\u00e9decine Tropical"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1986.224"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/152.4.807"},{"key":"e_1_2_5_9_1","first-page":"771","article-title":"A longitudinal study of endemic urinary Schistosomiasis in a small East African Community.","volume":"40","author":"Forsyth DM","year":"1969","journal-title":"Bulletin of the World Health Organization"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0035-9203(90)90392-R"},{"key":"e_1_2_5_11_1","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4269\/ajtmh.1998.59.775","article-title":"Evolution of Schistosoma haematobium\u2010related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania.","volume":"59","author":"Hatz CF","year":"1998","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1988.39.295"},{"key":"e_1_2_5_13_1","unstructured":"Organisation Mondiale de la Sant\u00e9(1991)Proposal for a practical guide to the standardized use of ultrasound in the assessement of the pathological changes. Meeting on ultrasonography in schistosomiasis. 1\u20134 October 1990 Cairo Egypt. Document TDR\/SCH\/ULTRASON\/91.3. Gen\u00e8ve Suisse."}],"container-title":["Tropical Medicine &amp; International Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-3156.2001.00660.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-3156.2001.00660.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:42:16Z","timestamp":1697258536000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-3156.2001.00660.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1046\/j.1365-3156.2001.00660.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-3156.2001.00660.x","archive":["Portico"],"relation":{},"ISSN":["1360-2276","1365-3156"],"issn-type":[{"value":"1360-2276","type":"print"},{"value":"1365-3156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}